Synthesis and enzymatic stability of PEGylated oligonucleotide duplexes and their self-assemblies with polyamidoamine dendrimers

被引:30
作者
Elsabahy, Mahmoud [1 ]
Zhang, Mingzhen [1 ]
Gan, Shao-Ming [1 ]
Waldron, Karen C. [1 ]
Leroux, Jean-Christophe [1 ]
机构
[1] Univ Montreal, Fac Pharm, Dept Chem, Montreal, PQ H3C 3J7, Canada
关键词
D O I
10.1039/b714221h
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 [物理化学]; 081704 [应用化学];
摘要
The objectives of the current study were to design and characterize poly(ethylene glycol) (PEG)based carriers for antisense oligonucleotide (AON) delivery that would gradually release the AON upon the enzymatic degradation of a complementary nuclease-sensitive sequence (SON). A phosphodiester SON was conjugated to one extremity or to the central part of PEG (molecular weight 10 or 20 K). The PEG-SON was hybridized to a nuclease-resistant phosphorothioate AON analog. Compared to the non-PEGylated duplex, the PEG-SON/AON derivative had a modest impact on the degradation kinetics of SON as monitored by a fluorescence dequenching assay performed in the presence of DNase 1. The reaction rate depended on the grafting position of SON and on the PEG's molecular weight. To further control the release rate, PEG-SON/AON conjugates were complexed to poly(amidoamine) (PAMAM) dendrimers of different generations (G). Interaction with PAMAMs of G3 and G5 yielded monodisperse polyion complex micelles (PICMs) with average mean sizes ranging from 70 to 100 nm. The PICMs were found to decrease the catalytic reaction rate by 20 to 100 fold; the slowest release kinetics being achieved with PEG(10K)-SON/AON/G5 PAMAM. The PEGylated conjugates reported in this manuscript as well as their self-assemblies with PAMAMs, could prove potentially useful to confer prolonged circulating properties to nucleic acid drugs and release them in a sustained manner.
引用
收藏
页码:294 / 302
页数:9
相关论文
共 42 条
[1]
PHARMACOKINETICS, BIODISTRIBUTION, AND STABILITY OF OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATES IN MICE [J].
AGRAWAL, S ;
TEMSAMANI, J ;
TANG, JY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (17) :7595-7599
[2]
Using ethidium bromide to probe the interactions between DNA and dendrimers [J].
Chen, W ;
Turro, NJ ;
Tomalia, DA .
LANGMUIR, 2000, 16 (01) :15-19
[3]
Crooke ST, 1996, J PHARMACOL EXP THER, V277, P923
[4]
Improvement of in vivo stability of phosphodiester oligonucleotide using anionic liposomes in mice [J].
De Oliveira, MC ;
Boutet, V ;
Fattal, E ;
Boquet, D ;
Grognet, JM ;
Couvreur, P ;
Deverre, JR .
LIFE SCIENCES, 2000, 67 (13) :1625-1637
[5]
Antisense oligonucleotide-based therapeutics for cancer [J].
Dean, NM ;
Bennett, CF .
ONCOGENE, 2003, 22 (56) :9087-9096
[6]
Characterization of complexes of oligonucleotides with polyamidoamine starburst dendrimers and effects on intracellular delivery [J].
DeLong, R ;
Stephenson, K ;
Loftus, T ;
Fisher, M ;
Alahari, S ;
Nolting, A ;
Juliano, RL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (06) :762-764
[7]
Dias N, 2002, MOL CANCER THER, V1, P347
[8]
Dendrimers in gene delivery [J].
Dufès, C ;
Uchegbu, IF ;
Schätzlein, AG .
ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (15) :2177-2202
[9]
Study of the micellization behavior of different order amino block copolymers with heparin [J].
Dufresne, MH ;
Leroux, JC .
PHARMACEUTICAL RESEARCH, 2004, 21 (01) :160-169
[10]
Eichman, 2000, Pharm Sci Technol Today, V3, P232, DOI 10.1016/S1461-5347(00)00273-X